California Public Employees Retirement System
CHRS icon

California Public Employees Retirement System’s Coherus Oncology CHRS Stock Holding History

California Public Employees Retirement System’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-117,700
Closed -$1.72M – 1810
2021
Q1 		$1.72M Sell
117,700
-10,930
-8% -$186K ﹤0.01% 2116
2020
Q4 		$2.24M Sell
128,630
-2,500
-2% -$44.5K ﹤0.01% 1924
2020
Q3 		$2.4M Buy
131,130
+3,000
+2% +$55.8K ﹤0.01% 1716
2020
Q2 		$2.29M Sell
128,130
-11,354
-8% -$192K ﹤0.01% 1713
2020
Q1 		$2.26M Sell
139,484
-66,424
-32% -$1.23M ﹤0.01% 1534
2019
Q4 		$3.71M Buy
205,908
+91,258
+80% +$1.68M ﹤0.01% 1645
2019
Q3 		$2.32M Buy
114,650
+96,014
+515% +$1.92M ﹤0.01% 1798
2019
Q2 		$412K Buy
18,636
+7,500
+67% +$130K ﹤0.01% 2614
2019
Q1 		$152K Buy
+11,136
New +$149K ﹤0.01% 2986
2016
Q1 		– Sell
-14,300
Closed -$328K – 3592
2015
Q4 		$328K Buy
+14,300
New +$368K ﹤0.01% 2989

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

California Public Employees Retirement System's CHRS Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Coherus Oncology (CHRS) in Q2 2021, closing a stake of 117,700 shares — an estimated $1.72M sold.

California Public Employees Retirement System first reported a position in CHRS in Q4 2015 and held it in 10 quarters. The position peaked at $3.71M in Q4 2019. 188 funds tracked by Wall St. Rank hold CHRS as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Coherus Oncology position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 117,700 Coherus Oncology shares in Q2 2021, an estimated $1.72M.
  • California Public Employees Retirement System first reported a position in Coherus Oncology in Q4 2015 and held it in 10 quarters.
  • California Public Employees Retirement System's Coherus Oncology position peaked at $3.71M in Q4 2019.
  • 188 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.